Published in J Autoimmun on February 01, 2014
Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor. Nat Med (2016) 1.38
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis. Arthritis Res Ther (2016) 1.37
Interleukin 33 is a guardian of barriers and a local alarmin. Nat Immunol (2016) 1.04
Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. Mucosal Immunol (2015) 0.98
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med (2015) 0.93
Regulatory B10 cell development and function. Int Immunol (2015) 0.90
T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis. Mucosal Immunol (2015) 0.87
Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B Cells. Cell Rep (2015) 0.86
B cell regulation of the anti-tumor response and role in carcinogenesis. J Immunother Cancer (2016) 0.86
Regulatory CD8(+)CD122 (+) T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells. Metab Brain Dis (2014) 0.84
Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine (2014) 0.84
Potential importance of B cells in aging and aging-associated neurodegenerative diseases. Semin Immunopathol (2017) 0.83
Cytokines and mucosal immunity. Curr Opin Gastroenterol (2014) 0.83
Role of type 2 immunity in intestinal inflammation. Curr Opin Gastroenterol (2015) 0.80
Immunological events in chronic spontaneous urticaria. Clin Transl Allergy (2015) 0.79
IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function. Inflamm Bowel Dis (2015) 0.79
Evidence of perturbations of the cytokine network in preterm labor. Am J Obstet Gynecol (2015) 0.79
CD19+CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer. Oncotarget (2015) 0.78
Altered gp130 signalling ameliorates experimental colitis via myeloid cell-specific STAT3 activation and myeloid-derived suppressor cells. Sci Rep (2016) 0.78
Activated mast cells promote differentiation of B cells into effector cells. Sci Rep (2016) 0.77
Immune Regulation and Antitumor Effect of TIM-1. J Immunol Res (2016) 0.75
IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model. Oncotarget (2017) 0.75
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases. Front Immunol (2017) 0.75
Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 22.57
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity (2005) 14.95
Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity (1994) 9.63
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest (1996) 7.97
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity (2008) 6.73
Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature (2011) 6.43
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A (2006) 5.08
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity (2002) 4.60
Prevention of arthritis by interleukin 10-producing B cells. J Exp Med (2003) 4.27
Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol (2009) 3.80
IL-33 reduces the development of atherosclerosis. J Exp Med (2008) 3.59
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol (1990) 3.55
Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med (1998) 3.53
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A (2009) 3.39
Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol (1992) 3.39
B-cell suppression of delayed hypersensitivity reactions. Nature (1974) 3.37
ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol (2004) 3.19
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem (2007) 3.11
Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol (2007) 3.09
Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol (2007) 2.99
IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol (2007) 2.93
T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med (1996) 2.79
The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci U S A (2004) 2.61
Studies with IL-10-/- mice: an overview. J Leukoc Biol (1997) 2.46
B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol (2007) 2.43
IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol (2007) 2.43
Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest (2011) 2.40
The 'short' history of regulatory B cells. Trends Immunol (2007) 2.38
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc Natl Acad Sci U S A (2010) 2.22
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut (2012) 1.97
Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol (2012) 1.85
Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci U S A (2005) 1.71
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol (2010) 1.58
IL-33-activated dendritic cells are critical for allergic airway inflammation. Eur J Immunol (2011) 1.57
An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity (2005) 1.53
Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol (2005) 1.47
Interleukin-33 ameliorates experimental colitis through promoting Th2/Foxp3⁺ regulatory T-cell responses in mice. Mol Med (2012) 1.37
B cell developmental requirement for the G alpha i2 gene. J Immunol (2003) 1.31
Interleukin-33 and the function of innate lymphoid cells. Trends Immunol (2012) 1.20
The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. J Immunol (2009) 1.19
IL-33 attenuates development and perpetuation of chronic intestinal inflammation. Inflamm Bowel Dis (2012) 1.19
Molecular cloning of the murine ST2 gene. Characterization and chromosomal mapping. Biochim Biophys Acta (1991) 1.19
Regulation of cellular antibody synthesis effect of adoptively transferred antibody-producing spleen cells on cellular antibody synthesis. J Immunol (1968) 1.19
New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine (2012) 1.17
Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains. Eur J Immunol (2005) 1.12
IL-33: a sheep in wolf's clothing? Sci STKE (2007) 1.07
Interleukin-33 exacerbates acute colitis via interleukin-4 in mice. Immunology (2013) 1.07
Nucleotide sequence of a complementary DNA for human ST2. Biochim Biophys Acta (1992) 1.03
IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol (2011) 1.01
A direct inhibitor of HMGB1 cytokine. Chem Biol (2007) 1.00
A role for interleukin-33 in T(H)2-polarized intestinal inflammation? Mucosal Immunol (2011) 1.00
Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis. Int J Mol Med (2011) 0.97
Feedback suppression of the immune response in vivo. I. Immune B cells induce antigen-specific suppressor T cells. Cell Immunol (1982) 0.92
An essential protective role of IL-10 in the immunological mechanism underlying resistance vs. susceptibility to lupus induction by dendritic cells and dying cells. Rheumatology (Oxford) (2011) 0.89
Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol (2011) 1.17
Vitrification of Tokuyasu-style immuno-labelled sections for correlative cryo light microscopy and cryo electron tomography. J Struct Biol (2014) 0.83
Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment. PLoS Pathog (2016) 0.81
Rapamycin and omega-1: mTOR-dependent and -independent Th2 skewing by human dendritic cells. Immunol Cell Biol (2013) 0.80
CD4+CD25hiFOXP3+ Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel. PLoS Negl Trop Dis (2015) 0.80